Genops Bioinformatics, based in Vancouver, BC, has appointed Ian Dunham to its scientific advisory board.
Dunham has worked as senior research fellow in human genetics at the Sanger Center since 1996, where he has overseen Human Chromosome projects 6 and 22. Previous to Sanger, Dunham held research positions at the United Medical and Dental Schools of Guy’s and St. Thomas’ Hospitals’ Division of Medical and Molecular Genetics and the Howard Hughes Medical Institute.
Celera Genomics of Rockville, Md., has appointed Lothar Krinke as vice president, business development and strategic planning.
Krinke’s focus will be on business development and potential mergers and acquisitions directed toward Celera’s Discovery Sciences strategy and the expansion of the group’s Information business.
Prior to Celera, Krinke was a vice president at consulting firm A.T. Kearney, where he was responsible for helping biopharmaceutical companies develop R&D and marketing strategies.
Larry Kier has joined Sante Fe, N.M.-based Phase-1 Molecular Toxicology as director of preclinical research.
Formerly at Monsanto/Pharmacia, Kier will oversee the company’s data mining activities and help develop predictive toxicology methods. He will also contribute to the analysis of data from the company’s TOXbank Canine Database scheduled for release in early 2002.